Inebilizumab for neuromyelitis optica spectrum disorders. Schindler, P. and Paul, F. touchREVIEWS in Neurology 20 (1): 16-22. 2024
![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
![[up]](/style/images/multi_up.png)
Up a level
